Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix for Moderate to Severe Endometriosis-Associated Pain (ELARIS EM-I)
NCT01620528Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2012
- Primary completion
- Nov 2014
01
Overview
A Phase 3 trial of elagolix in endometriosis, sponsored by AbbVie Inc.. Started May 2012; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01620528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620528.